http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2688218-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944f0be5b782464c15e0c9cb802ab561 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
filingDate | 1992-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84026cc322ce5916a606a39843952069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a481ec631904ad8e5ca0a6966d4236a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daf9456cede8a9e0bd7fdd01ee3e8799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a73a954b0e546f897c2c6ab612ccf9 |
publicationDate | 1993-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2688218-A1 |
titleOfInvention | QUATERNARY AMMONIUM SALTS OF AMINOUS AROMATIC COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
abstract | The present invention relates to quaternary ammonium salts of formula: (CF DRAWING IN BOPI) in which: - J represents either an Ar-CXX'-CX "group or an Ar- (CH2) x CX1 group in which: . Ar represents an optionally substituted phenyl; a cycloalkyl; a pyridyl or a thienyl;. X represents hydrogen;. X 'represents hydrogen or is joined to X "below to form a carbon-carbon bond or else X and X 'together form an oxo group; . X "is hydrogen or together with X 'forms a carbon-carbon bond; x is zero or one;. X1 represents hydroxyl, alkoxy; acyloxy; carboxy; carbalkoxy; cyano; alkoxyamino group; - Q represents an alkyl group or a benzyl group; - A- represents an anion; - m is 2 or 3; - Ar 'represents an optionally substituted phenyl; a thienyl; a benzothienyl or a naphthyl; - R represents hydrogen, or an alkyl in C1 -C6; - T represents chosen from -CO- or -CW-NH- W being an oxygen or sulfur atom, and - Z represents either hydrogen, or M or OM when T represents the group -CO - Or M when T represents the group -CW-NH-; M represents in particular an alkyl, a phenylalkyl, a pyridylalkyl, a naphthyl or a naphthylalkyl, a pyridylthioalkyl or a styryl. APPLICATION: medicaments in particular for the treatment of pathological phenomena which involves the neurokinin system. |
priorityDate | 1992-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.